Guangdong Pharmaceutical bidding plan has been submitted for review, and pharmaceutical enterprises are eager to delete the word "lowest price winning bid"

June 14, 2013 Author: Reporter Zeng Liangliang / source of Beijing report: economic reference newspaper "the draft submitted for review has been modified on the original basis, but it is all technical changes, and there is no change in essence." At the Symposium of CPPCC members of the National People's Congress of the pharmaceutical industry held recently, the reporter learned that the draft of Guangdong drug bidding scheme has been submitted to the Guangdong Provincial Government for review and has been modified on the basis of the original However, the "lowest bid, 10 points for technical bid and 90 points for commercial bid" which are the most vocal objections of enterprises have not been revised On May 17, the office of Guangdong Provincial Leading Group for centralized drug purchase issued the notice on Soliciting Opinions on the revision of relevant rules of drug trade in Guangdong Province (Draft for comments) (hereinafter referred to as the notice), and issued the drug trade rules of Guangdong Province (Trial) and the basic drug trade rules of Guangdong Province (Trial) 》Five related documents (Guangdong plan for short) including Guangdong drug transaction purchase and distribution rules (for Trial Implementation) are online for public comments On May 28, China over the counter Pharmaceutical Association, China Chemical Pharmaceutical Industry Association, China Association of traditional Chinese medicine, China Association for the promotion of scientific research and development of pharmaceutical industry and China Association for the management of pharmaceutical enterprises jointly wrote to the Guangdong provincial government, hoping to amend the contents of the Guangdong plan "The plan puts forward many cutting-edge things, such as online bidding, which have the spirit of reform, but there are also some unrealistic and infeasible things We haven't changed since we made a lot of comments " The chairman of a listed company attending the meeting told reporters At the symposium, the opinions of pharmaceutical enterprises against the Guangdong plan were concentrated on three points First, winning the bid at the lowest price, with 10 points for technical bid and 90 points for commercial bid According to the enterprise, "the government's spirit of encouraging innovation of pharmaceutical enterprises is not reflected, the profit space of pharmaceutical enterprises is not given, R & D investment is not carried out, and the development of national pharmaceutical industry in China is restrained." Second, purchase online once a month According to the company, "it's very difficult to do this What should I do if I bought too many varieties and didn't use them up last month? Doctors need to understand the names and indications of the drugs again in one month, which is very difficult to do It's also not conducive to observing the adverse reactions of the drugs." Third, priority should be given to purchasing foreign drugs The general manager of an enterprise pointed out: "drug procurement is government procurement, so we should purchase domestic products first The premise of domestic products is quality standards, and we should not give priority to purchasing foreign products The sales volume of foreign brand drugs in the major cities of the Pearl River Delta is close to 50% If this rule is followed, it is estimated that foreign drugs will account for 70% and 80% of the total in one or two years "